Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated The Times of IndiaPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins UpstoxICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll MintICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine ETHealthWorldFirst-ever Phase 3 clinical trial of made-in-India dengue vaccine begins in India The Financial Express
Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated – The Times of India
